Abstract Library

#4581 Clinical efficacy and safety of treatments for pancreatic and extra-pancreatic neuroendocrine tumours following treatment failure or disease progression: A systematic literature review

Introduction: Neuroendocrine tumours (NETs) are a diverse group of rare malignancies with few effective targeted treatments, highlighting a need for novel therapies.

Conference:

Presenting Author:

Authors: Karim E, Srirajaskanthan R, Bensegnor H, Chan K, Drane E,

Keywords: Neuroendocrine tumour, Systematic literature review,

#4576 Economic evidence for pancreatic and extra-pancreatic neuroendocrine tumours following treatment failure or disease progression: A systematic literature review

Introduction: Treatment failure and disease progression (PD) in neuroendocrine tumours (NETs), a rare group of malignancies, are common due to limited targeted treatments.

Conference:

Presenting Author:

Authors: Karim E, Sola-Morales O, Bensegnor H, Chan K, Drane E,

Keywords: Neuroendocrine Tumour, Systematic Literature Review, Economic,

#3640 Neuroendocrine tumor in a young patient

Introduction: This abstract is devoted to the clinical case of a young patient with pancreatic NET initially with lesions in the liver and clinical carcinoid syndrome.

Conference:

Presenting Author: Androsova A

Authors: Androsova A, Orlova R, Ivanova A, Belyak N, Kutukova S,

Keywords: NET, pancreas, young patient,

#3375 Neuroendocrine tumors associated with ovarian teratoma – One centre experience

Introduction: Ovarian teratomas are frequent gynaecological finding in contrary to ovarian NETs which comprise only 0.1% of all ovarian neoplasms. In contrast to other gynaecological organs like cervix, endometrium vagina or vulva in which the common type of NENs is NECs, in case of ovarian carcinoid the prognosis remains good.

Conference:

Presenting Author: Opalinska M

Authors: Opalinska M, Sowa-Staszczak A, Olearskaa H, Ulatowska-Bialas M, Gilis-Januszewska A,

Keywords: ovarian carcinoid, NET, teratoma, outcome,